ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LEGN Legend Biotech Corporation

44.69
-0.48 (-1.06%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Legend Biotech Corporation LEGN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.48 -1.06% 44.69 20:00:00
Open Price Low Price High Price Close Price Prev Close
44.94 44.06 45.19 44.42 45.17
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/22/202413:05BWCARVYKTI® (ciltacabtagene autoleucel) Approved by the..
4/11/202408:00BWLegend Biotech to Host Investor Conference Call on First..
4/05/202423:30BWLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel)..
3/19/202408:30BWLegend Biotech Announces Publication of Inaugural..
3/15/202415:15BWCARVYKTI® (ciltacabtagene autoleucel) Receives..
3/11/202407:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/11/202407:00BWLegend Biotech Reports Fourth Quarter and Full Year 2023..
3/11/202406:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
2/28/202418:46EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2/27/202419:47EDGAR2Form 144 - Report of proposed sale of securities
2/23/202413:10EDGAR2Form 144 - Report of proposed sale of securities
2/23/202407:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/23/202407:15BWLegend Biotech Announces Positive CHMP Opinion for CARVYKTI®..
2/14/202420:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202408:00BWLegend Biotech to Host Investor Conference Call on Fourth..
1/23/202409:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/23/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/09/202416:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202411:28BWLegend Biotech Announces Closing of License Transaction for..
1/03/202408:30BWLegend Biotech Announces Closing of License Transaction for..
1/02/202408:30BWLegend Biotech to Participate in the 42nd Annual J.P. Morgan..
12/27/202310:00EDGAR2Form 144 - Report of proposed sale of securities
12/22/202315:38EDGAR2Form 144 - Report of proposed sale of securities
12/22/202315:21EDGAR2Form 144 - Report of proposed sale of securities
12/21/202317:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202316:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202314:31EDGAR2Form 144 - Report of proposed sale of securities
12/11/202319:30BWPatient-Reported Outcomes from the CARTITUDE-4 Study Showed..
11/20/202306:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
11/20/202306:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/20/202306:00BWLegend Biotech Reports Third Quarter 2023 Results and Recent..
11/13/202309:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
11/13/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/13/202308:30BWLegend Biotech Announces Exclusive, Global License Agreement..
11/07/202308:30BWLegend Biotech to Host Investor Conference Call on..
11/02/202309:17BWLegend Biotech to Showcase Leadership in Multiple Myeloma..
10/17/202317:39EDGAR2Form 144 - Report of proposed sale of securities
10/17/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/16/202317:20EDGAR2Form 144 - Report of proposed sale of securities
9/27/202312:02EDGAR2Form 144 - Report of proposed sale of securities
9/25/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202316:20EDGAR2Form 144 - Report of proposed sale of securities
9/22/202316:10EDGAR2Form 144 - Report of proposed sale of securities
9/18/202316:41EDGAR2Form 144 - Report of proposed sale of securities
8/28/202310:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/21/202316:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/15/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/15/202306:00BWLegend Biotech Reports Second Quarter 2023 Results and..
8/03/202308:30BWLegend Biotech to Host Investor Conference Call on..
7/20/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock